4DMedical Limited
FDMDF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 2.2% | -2.2% | 273.7% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 90.7% | 93.5% | -525.6% | -1,616.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -797.7% | -775.4% | -749.2% | -1,219.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -368.5% | -662% | -687.8% | -1,969.3% |
| EPS Diluted | -0.17 | -0.031 | -0.068 | -0.042 |
| % Growth | -448.4% | 54.4% | -61.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |